BRPI0817118A2 - composições farmacêuticas liofilizadas - Google Patents

composições farmacêuticas liofilizadas

Info

Publication number
BRPI0817118A2
BRPI0817118A2 BRPI0817118A BRPI0817118A BRPI0817118A2 BR PI0817118 A2 BRPI0817118 A2 BR PI0817118A2 BR PI0817118 A BRPI0817118 A BR PI0817118A BR PI0817118 A BRPI0817118 A BR PI0817118A BR PI0817118 A2 BRPI0817118 A2 BR PI0817118A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
lyophilized pharmaceutical
lyophilized
compositions
pharmaceutical
Prior art date
Application number
BRPI0817118A
Other languages
English (en)
Inventor
Zobel Hans-Peter
Zhu Jiahao
Lawrence Zielinski Joseph
Buranachokpaisan Thitiwan
Tong Wei-Qin
Jiang Wenlei
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40005335&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0817118(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0817118A2 publication Critical patent/BRPI0817118A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0817118A 2007-09-20 2008-09-18 composições farmacêuticas liofilizadas BRPI0817118A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97383007P 2007-09-20 2007-09-20
PCT/US2008/076752 WO2009039226A1 (en) 2007-09-20 2008-09-18 Lyophilized pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0817118A2 true BRPI0817118A2 (pt) 2019-09-24

Family

ID=40005335

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817118A BRPI0817118A2 (pt) 2007-09-20 2008-09-18 composições farmacêuticas liofilizadas

Country Status (20)

Country Link
US (1) US20100331387A1 (pt)
EP (1) EP2205222A1 (pt)
JP (1) JP2010540445A (pt)
KR (1) KR20100059887A (pt)
CN (1) CN101801345A (pt)
AR (1) AR068822A1 (pt)
AU (1) AU2008302273A1 (pt)
BR (1) BRPI0817118A2 (pt)
CA (1) CA2696914A1 (pt)
CL (1) CL2008002786A1 (pt)
CO (1) CO6270207A2 (pt)
EC (1) ECSP10010039A (pt)
GT (1) GT201000062A (pt)
MA (1) MA31744B1 (pt)
MX (1) MX2010002970A (pt)
PE (1) PE20090706A1 (pt)
RU (1) RU2010115262A (pt)
TN (1) TN2010000097A1 (pt)
TW (1) TW200930416A (pt)
WO (1) WO2009039226A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2743740T3 (es) * 2016-03-31 2020-02-20 Midatech Ltd Aducto de ciclodextrina-panobinostat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
US7250514B1 (en) * 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
RS52625B (en) * 2003-07-23 2013-06-28 Bayer Healthcare Llc FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
JP2007501775A (ja) * 2003-08-07 2007-02-01 ノバルティス アクチエンゲゼルシャフト 免疫抑制剤としてのヒストンデアセチラーゼ阻害剤
PE20060664A1 (es) * 2004-09-15 2006-08-04 Novartis Ag Amidas biciclicas como inhibidores de cinasa
US20060128660A1 (en) * 2004-12-10 2006-06-15 Wisconsin Alumni Research Foundation FK228 analogs and methods of making and using the same
US7604939B2 (en) * 2005-03-01 2009-10-20 The Regents Of The University Of Michigan Methods of identifying active BRM expression-promoting HDAC inhibitors
KR20090098920A (ko) * 2007-01-10 2009-09-17 노파르티스 아게 데아세틸라제 억제제의 제제
KR20090110913A (ko) * 2007-02-15 2009-10-23 노파르티스 아게 Ｌｂｈ589와 암을 치료하기 위한 다른 치료제와의 조합물

Also Published As

Publication number Publication date
CA2696914A1 (en) 2009-03-26
MX2010002970A (es) 2010-04-01
US20100331387A1 (en) 2010-12-30
ECSP10010039A (es) 2010-04-30
CL2008002786A1 (es) 2009-05-15
TW200930416A (en) 2009-07-16
MA31744B1 (fr) 2010-10-01
KR20100059887A (ko) 2010-06-04
WO2009039226A1 (en) 2009-03-26
CN101801345A (zh) 2010-08-11
AU2008302273A1 (en) 2009-03-26
CO6270207A2 (es) 2011-04-20
GT201000062A (es) 2012-03-30
RU2010115262A (ru) 2011-10-27
TN2010000097A1 (en) 2011-09-26
EP2205222A1 (en) 2010-07-14
JP2010540445A (ja) 2010-12-24
AR068822A1 (es) 2009-12-09
PE20090706A1 (es) 2009-07-15

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
LTPA2018014I1 (lt) Farmacinė kompozicija 514
DK2079456T3 (da) Farmaceutiske cyclosporinsammensætninger
RU2493831C3 (ru) Фармацевтические композиции
BRPI0721651A2 (pt) Composição farmacêutica
SMT201600259B (it) Composizioni farmaceutiche antibatteriche
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0810634A2 (pt) Composições fungicidas
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0813775A2 (pt) Composição
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
BRPI0820198A2 (pt) composições farmacêuticas
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0816995A2 (pt) Composições de ciclosporina
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
BRPI0811002A2 (pt) Composição biofertilizante

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.